# PolyCore Therapeutics, Inc. — Form D

PolyCore Therapeutics, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-17. The offering totals $4.7M, of which $4.7M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-03-17
- Form: D
- Accession: 0001567619-22-007140
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.7M
- Amount sold: $4.7M
- Investors: 5
- Date of first sale: 2022-02-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-437808

## Issuer

- Name: PolyCore Therapeutics, Inc.
- CIK: 0001914733
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 3180 CHESTNUT STREET, SUITE 104, PHILADELPHIA, PA, 19104
- Phone: 484-888-2661

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Kelly Beck | Director | Philadelphia, PA |
| Frederick Callori | Director | Philadephia, PA |
| Christopher B Cashman | Director | Philadelphia, PA |
| Chris Garabedian | Director | San Francisco, CA |
| James B Harris | Director | Philadelphia, PA |
| Kelly Beck | Executive Officer | Philadelphia, PA |
| Kelly Beck | Promoter | Philadelphia, PA |

## More

- [CIK 1914733 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1914733&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001567619-22-007140.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.